Alessandra Curioni Fontecedro
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Alessandra Curioni Fontecedro
Jun 10, 2024, 10:01 |
Blog
Alessandra Curioni Fontecedro: Giuseppe Curigliano represents ESMO for me
Alessandra Curioni Fontecedro, Head of Medical Oncology at HFR Fribourg – Cantonal Hospital, shared Antonio…
May 25, 2024, 06:44 |
Insight
The third cohort of the Certificate of Advanced Studies in Lung Cancer - European School of Oncology
European School of Oncology shared on LinkedIn: “The third cohort of the Certificate of Advanced…
May 20, 2024, 15:34 |
Blog
Alessandra Curioni Fontecedro: Gaëlle Rhyner is a fantastic colleague fully dedicated to patients and head of Lymphoma group
Alessandra Curioni Fontecedro, Head of Medical Oncology at the HFR Fribourg – Cantonal Hospital, shared…
Nov 28, 2023, 17:47 |
Blog
Alessandra Curioni Fontecedro: The team is looking forward to welcoming Anurag Gupta and working together soon
Quoting Alessandra Curioni Fontecedro, Head of Medical Oncology at the HFR Fribourg – Cantonal Hospital,…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube